Skip to main content
Clinical Trials/NL-OMON33642
NL-OMON33642
Completed
Not Applicable

A prospective explorative cross sectional clinical study to investigate the neurocognitive effects of human Immunodeficiency virus and the influence of highly active anti retroviral (HAART) therapy on CSF viral replication and biomarkers for neurodegeneration in HIV infected patients on chronic therapy with HAART - Neurona-light

niversitair Medisch Centrum Sint Radboud0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neuro-HIV
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • HIV\-seropositive 18\-65 years
  • On HAART therapy

Exclusion Criteria

  • Active opportunistic infection
  • Active psychiatric disorder for which treatment is indicated
  • Malignancy
  • Neurosyphilis
  • Drug addiction
  • Excessive (\> 2 U/d) use of alcohol

Outcomes

Primary Outcomes

Not specified

Similar Trials